Legal status by country
Is Kisspeptin-54 legal?
Written by Aaron CuhaReviewed Sep 2026
How Kisspeptin-54 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | No approved product. The published human trials are investigator-led phase 2 studies run in the United Kingdom. | The main clinical programme was conducted at Imperial College London and Hammersmith Hospital under research authorisation, not a marketing licence. | None recorded | None recorded |
US FDA status: Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.